Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 3:52 AM UTC
| NCT Number | NCT07106762 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE2 |
| Target Enrollment | 470 participants |
| Active Locations | 35 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | July 29, 2026 (Jul 29, 2026) |
As of August 29, 2026: Clinical trial NCT07106762 is currently recruiting participants. This phase2 study for bladder cancer is actively seeking new participants at 35 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07106762 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07106762 was last updated Jul 29, 2026 (July 29, 2026). HelloStudys verifies this status automatically.